Skip to content
RKWD
ROCKWOOD RESEARCH · A CORPORATE FILINGS WEBSITE|STRAIGHT FROM THE SOURCE · SEC EDGAR|SPONSOREDYour message on this tape — bid on the Rockwood Ad Exchange · Rockwood Ad Exchange|
Rockwood Research
…

ASMB

ASSEMBLY BIOSCIENCES, INC.

Pharmaceutical Preparations · SIC 2834CIK 1426800Held by 1 tracked managerEDGAR filings ↗10-K/10-Q ↗

SHARE:XLINKEDINEMAIL
Revenue FY2025
$72.0M
Net Income FY2025
$(6.0M)
EPS (Basic, as reported)
$-0.55
Net Margin FY2025
-8.5%
ROE FY2025
-3.0%
Total Equity
$207.0M
Shares Out
20M
Business description

ASSEMBLY BIOSCIENCES, INC. — Pharmaceutical Preparations. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2007–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.

Annual (fiscal years, as reported)USD millions
i
default rows · click any row to chart itRevenue: 0 → 72
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022⚑FY2023FY2024⚑FY2025
Revenue091516796072972
Research & development(33)(44)(73)(86)(107)(69)(70)(49)(56)(65)
General & administrative(12)(17)(35)(33)(37)(29)(24)(23)(18)(20)
Total operating expenses—(61)(108)(119)(144)(139)(94)(72)(74)(84)
Operating income(45)(52)(93)(103)(65)(133)(94)(65)(45)(12)
Interest expense——————————
Interest & investment income——————————
Other income (expense), net0034301366
Pre-tax income(45)(52)(90)(98)(62)(132)(93)(61)(40)(6)
Income tax expense(1)(9)(1)(1)0(3)0000
Net income(44)(43)(91)(98)(62)(130)(93)(61)(40)(6)
EPS — basic—————($3.00)($1.92)($13.38)($6.69)($0.55)
EPS — diluted—————($3.00)($1.92)($13.38)($6.69)($0.55)
Shares outstanding — basic (M)—————43485611
Shares outstanding — diluted (M)—————43485611

Showing the latest 10 of 19 fiscal years.

  • ⚑ Weighted-average shares changed ÷10.00 between FY2022 and FY2023 — likely a reverse split. Per-share figures on either side are as reported and not adjusted.
  • ⚑ Weighted-average shares changed ×1.83 between FY2024 and FY2025 — likely a stock split. Per-share figures on either side are as reported and not adjusted.

Source: SEC EDGAR XBRL company facts — figures as reported in each period's original filing (structured data begins ~2008). EPS and other per-share figures are as reported and are not adjusted for later stock splits; a ⚑ marks a period where the reported share count changed by a large factor. Dollar figures in millions unless per-share. Line items a company never reports are omitted. Where a filer switched XBRL concepts, the successor concept is used and definitions can differ slightly (e.g. cash may include restricted cash; banks' revenue is net of interest expense; cost of revenue may exclude D&A; net income may be the amount available to common stockholders; debt issued/repaid may be net of issuance costs or include finance-lease obligations — each only where the original concept stopped being reported). Click a period header to open that period's source filing on EDGAR.